ADAPTIMMUNE THERAPEUTICS PLC
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $123.6M | $50.4M |
| FY2020 | — | $341.2M | $56.9M |
| FY2021 | — | $206.0M | $149.9M |
| FY2022 | — | $81.9M | $108.0M |
| FY2023 | — | $39.5M | $144.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $123.6M | $50.4M |
| FY2020 | — | $341.2M | $56.9M |
| FY2021 | — | $206.0M | $149.9M |
| FY2022 | — | $81.9M | $108.0M |
| FY2023 | — | $39.5M | $144.0M |